Last updated 30 days ago

Systemic Vibratory Therapy and Osteopathic Manipulative Treatment in Individuals With Obesity

90 patients around the world
Available in Brazil
For anamnesis, data is collected from participants, including age, sex, smoking status, alcohol consumption, presence and type of diabetes mellitus, presence of systemic arterial hypertension, associated comorbidities, medication use, history of COVID-19, and physical inactivity. Clinical assessments are conducted before and after the 12 sessions of systemic vibratory therapy, including measurements of systemic blood pressure, heart rate variability, heart rate, oxygen saturation, respiratory rate, the BORG scale and the Numeric Pain Scale (NPS). Anthropometric measurements were collected, including neck, arm, abdominal, hip, thigh and ankle circumferences, as well as body composition distribution assessed via bioelectrical impedance, and lumbar spine flexibility via anterior trunk flexion test. Laboratory analyses of relevant biomarkers, the HOMA-IR index, and anthropometric indicators were also evaluated. Questionnaires were administered to assess quality of life. Neuromuscular activity is assessed using handgrip strength via a manual dynamometer. Heart rate variability is assessed using a heart rate monitor. Patients were positioned on the platform base under the supervision of a healthcare professional to perform the interventions.
Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas
90Patients around the world

This study is for people with

Obesity

Requirements for the patient

To 65 Years
All Gender

Medical requirements

Individuals of both sexes.
Individuals with obesity.
Over 18 years old.
Body mass index (BMI) < 30 kg/m2.
Uncontrolled untreated hypertension, with elevated systemic blood pressure levels (≥180 x 110 mmHg).
Cardiovascular diseases (myocardial infarction/stroke), in the last 6 months.
Atrial fibrillation.
History of spine surgery.
Neurological, rheumatological diseases or osteoarticular lesions that hinder movements of the vibrating platform (VP).
Serious or disabling diseases, at the discretion of the investigator.
Individuals who refuse to sign the Informed Consent Form (ICF) to participate in the study.
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy